Xeltis expands leadership team with appointment of Luc Verhees as Vice President of Clinical Business Development
- Brings over 30 years of experience in cardiovascular clinical research, business development, training, education, and medical affairs
- Strengthens Xeltis’ leadership team following IDE approval for initiation of US pivotal study for aXessTM, its restorative vascular access conduit
EINDHOVEN, The Netherlands, 5 November 2024 – Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces that it has appointed Luc Verhees as its new Vice President of Clinical Business Development.
